Arrowstreet Capital’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-75,312
Closed -$685K 2054
2025
Q2
$685K Sell
75,312
-282,163
-79% -$2.08M ﹤0.01% 1686
2025
Q1
$3.23M Buy
+357,475
New +$3.77M ﹤0.01% 1151
2024
Q4
Sell
-88,027
Closed -$1.38M 1912
2024
Q3
$1.38M Sell
88,027
-38,956
-31% -$590K ﹤0.01% 1312
2024
Q2
$1.71M Sell
126,983
-232,640
-65% -$4.76M ﹤0.01% 1112
2024
Q1
$9.96M Buy
359,623
+336,423
+1,450% +$7.47M 0.01% 685
2023
Q4
$447K Buy
+23,200
New +$420K ﹤0.01% 1235
2023
Q3
Sell
-203,301
Closed -$3.87M 1373
2023
Q2
$3.87M Buy
+203,301
New +$3.63M ﹤0.01% 681
2020
Q4
Sell
-493,180
Closed -$12.4M 2465
2020
Q3
$12.4M Sell
493,180
-486,277
-50% -$7.09M 0.02% 746
2020
Q2
$7.46M Buy
979,457
+342,651
+54% +$2.51M 0.01% 890
2020
Q1
$5.83M Buy
636,806
+326,814
+105% +$1.97M 0.02% 682
2019
Q4
$1.6M Buy
309,992
+280,358
+946% +$1.8M ﹤0.01% 1203
2019
Q3
$172K Buy
+29,634
New +$133K ﹤0.01% 1473
2017
Q3
Sell
-194,089
Closed -$6.25M 1192
2017
Q2
$6.25M Sell
194,089
-53,605
-22% -$1.76M 0.02% 431
2017
Q1
$8.57M Buy
+247,694
New +$8.84M 0.03% 429

Other funds holding ACH

Arrowstreet Capital's ACH Position: Q3 2025 in Review

Arrowstreet Capital sold out of Accendra Health (ACH) in Q3 2025, closing a stake of 75,312 shares — an estimated $685K sold.

Arrowstreet Capital first reported a position in ACH in Q1 2017 and held it in 14 quarters. The position peaked at $12.4M in Q3 2020. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • Arrowstreet Capital reported no remaining Accendra Health position as of Q3 2025 after selling out during the quarter.
  • Arrowstreet Capital sold 75,312 Accendra Health shares in Q3 2025, an estimated $685K.
  • Arrowstreet Capital first reported a position in Accendra Health in Q1 2017 and held it in 14 quarters.
  • Arrowstreet Capital's Accendra Health position peaked at $12.4M in Q3 2020.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Arrowstreet Capital's 13F filing for Q3 2025, filed 13 Nov 2025.